Want to see CH:AEVS full AI Analyst Report?
Top Page
AEVIS VICTORIA SA
(AEVS)
Select Model
Select Model
Rating:45Neutral
Price Target:
CHF12.50
▼(-7.75% Downside)
Action:Reiterated
Date:08/04/26
The score is held down primarily by weak and inconsistent profitability combined with high leverage, despite steady revenue growth. Improving operating cash flow is a partial offset, but volatile/weak free cash flow remains a constraint. Technicals are largely neutral with the stock still below longer-term moving averages, and valuation is pressured by a negative P/E and lack of dividend support.
Positive Factors
Healthcare-focused investment model
A focused holding company model concentrated on hospitals, clinics and healthcare infrastructure creates durable cash and value-creation channels: operating income, dividends and eventual disposals. This specialization aligns with structural healthcare demand and enables operational oversight and synergies across assets.
Negative Factors
Elevated leverage
Debt materially exceeding equity raises financial risk and constrains strategic flexibility. High leverage increases interest and refinancing exposure, limits ability to fund expansions or survive shocks, and forces management to prioritize deleveraging or asset sales over accretive investments.
Read all positive and negative factors
Positive Factors
Negative Factors
Healthcare-focused investment model
A focused holding company model concentrated on hospitals, clinics and healthcare infrastructure creates durable cash and value-creation channels: operating income, dividends and eventual disposals. This specialization aligns with structural healthcare demand and enables operational oversight and synergies across assets.
Read all positive factors
AEVIS VICTORIA SA (AEVS) vs. iShares MSCI Switzerland ETF (EWL)
Market Cap
CHF1.10B
Dividend YieldN/A
Average Volume (3M)11.01K
Price to Earnings (P/E)―
Beta (1Y)-0.19
Revenue Growth17.29%
EPS Growth-596.20%
CountryCH
Employees4,870
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)-0.24
Shares Outstanding85,151,470
10 Day Avg. Volume5,888
30 Day Avg. Volume11,014
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)2.21
Price to Sales (P/S)0.99
P/FCF Ratio230.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF17.00Price Target Upside25.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.16
Revenue Forecast (FY)CHF1.10B
AEVIS VICTORIA SA Business Overview & Revenue Model
Company Description
Aevis Victoria SA is a Swiss holding company with diversified interests spanning the healthcare, hospitality, lifestyle, and infrastructure sectors. Its operational structure is divided into key segments: Hospitals, Hospitality, Telemedicine, and ...
How the Company Makes Money
AEVIS VICTORIA SA makes money primarily through the operating performance and value creation of its healthcare portfolio companies. Its economic model generally consists of: (1) Operating income generated by its healthcare services holdings (e.g.,...
AEVIS VICTORIA SA Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
38
Negative
Cash Flow
52
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.13B | 1.01B | 914.36M | 1.03B | 823.26M |
| Gross Profit | 193.03M | 789.90M | 170.09M | 185.41M | 137.56M |
| EBITDA | 24.91M | 92.49M | 49.06M | 128.29M | 83.47M |
| Net Income | -20.11M | -2.87M | -39.30M | 58.81M | -4.26M |
Balance Sheet | |||||
| Total Assets | 1.91B | 2.00B | 1.86B | 1.79B | 1.73B |
| Cash, Cash Equivalents and Short-Term Investments | 28.98M | 36.92M | 80.71M | 75.43M | 63.42M |
| Total Debt | 949.83M | 1.07B | 1.01B | 970.03M | 841.27M |
| Total Liabilities | 1.35B | 1.42B | 1.32B | 1.28B | 1.14B |
| Stockholders Equity | 509.75M | 530.85M | 491.89M | 469.34M | 485.92M |
Cash Flow | |||||
| Free Cash Flow | 4.87M | -18.80M | -66.06M | 40.28M | -24.07M |
| Operating Cash Flow | 72.56M | 46.50M | 42.67M | 114.30M | 33.53M |
| Investing Cash Flow | 56.05M | -62.28M | 35.56M | -56.82M | 21.63M |
| Financing Cash Flow | -136.51M | -28.06M | -72.95M | -45.46M | -57.31M |
AEVIS VICTORIA SA Technical Analysis
Negative
13.55
Price Trends
12.75
Positive
13.10
Negative
13.20
Negative
Market Momentum
0.06
Positive
48.93
Neutral
38.10
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:AEVS, the sentiment is Negative. The current price of 13.55 is above the 20-day moving average (MA) of 12.92, above the 50-day MA of 12.75, and above the 200-day MA of 13.20, indicating a neutral trend. The MACD of 0.06 indicates Positive momentum. The RSI at 48.93 is Neutral, neither overbought nor oversold. The STOCH value of 38.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CH:AEVS.
AEVIS VICTORIA SA Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | CHF3.90B | 13.27 | ― | 4.54% | -1.58% | 2.02% | |
62 Neutral | CHF4.35B | 19.82 | ― | 3.83% | -1.37% | 8.55% | |
59 Neutral | CHF2.54B | 142.53 | ― | 0.14% | -2.79% | -54.20% | |
57 Neutral | CHF1.32B | 81.25 | ― | 0.38% | -7.74% | -58.06% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
45 Neutral | CHF1.10B | -53.64 | ― | ― | 17.29% | -596.20% |
* General Sector Average
CH:AEVS
AEVIS VICTORIA SA
12.80
-0.35
-2.66%
CH:ADEN
Adecco Group AG
23.66
-1.58
-6.27%
CH:DKSH
DKSH Holding AG
68.90
13.91
25.30%
CH:COTN
COMET Holding AG
363.80
171.51
89.20%
CH:XLS
Xlife Sciences Ltd.
16.50
-4.90
-22.90%
CH:SKAN
SKAN Group AG
58.50
-8.59
-12.80%
AEVIS VICTORIA SA Corporate Events
MRH Switzerland Outperforms Soft Swiss Hotel Market with Higher Rates and Stable Margins
Aug 3, 2026
MRH Switzerland AG, the hotel arm of AEVIS VICTORIA, posted a 1.0% revenue increase to CHF 104.9 million in the first half of 2026, despite a slightly contracting Swiss hotel market. Accommodation and restaurant revenues both edged higher, with av...
AEVIS VICTORIA Backs Infracore’s CHF 200 Million IPO as Strategic Milestone
Jul 8, 2026
AEVIS VICTORIA SA has welcomed the confirmation of the final volume of the initial public offering of its strategic holding Infracore SA, a Swiss real estate company specializing in hospital and healthcare infrastructure. The IPO, which raises aro...
AEVIS VICTORIA Backs Infracore IPO to Highlight Healthcare Real Estate Value
Jun 30, 2026
AEVIS VICTORIA SA, a Swiss investment company listed on SIX Swiss Exchange, holds significant stakes in healthcare, lifestyle and infrastructure businesses, including Swiss Medical Network clinics, hotel chains and hospital real estate specialist ...
AEVIS VICTORIA Backs Infracore IPO Plan as Part of Investment Company Shift
Jun 16, 2026
AEVIS VICTORIA SA has welcomed Infracore SA’s intention to pursue an initial public offering, calling the planned flotation a key milestone in both Infracore’s growth and AEVIS’s ongoing shift into a transparent, value-focused in...
AEVIS VICTORIA shareholders back all proposals and re-elect board
May 21, 2026
AEVIS VICTORIA SA reported that shareholders at its Ordinary General Meeting for the 2025 financial year approved all proposals, including the adoption of the annual financial statements and the appropriation of retained earnings, with the CHF 455...
AEVIS VICTORIA lifts profitability on diversified Q1 growth
May 19, 2026
AEVIS VICTORIA SA delivered a solid first quarter of 2026, with consolidated net revenue rising 1.8% to CHF 299.1 million and profitability improving across key metrics, including a 14.9% increase in EBITDAR and a 53.2% jump in net profit before m...
AEVIS VICTORIA’s Hospitality Arm Grows Q1 Revenue as Swiss Hotel Market Normalizes
May 13, 2026
AEVIS VICTORIA’s hospitality division, MRH Switzerland, posted first-quarter 2026 revenue of CHF 67.8 million, up 1% year on year and outpacing a broadly flat Swiss hotel market that saw just 0.1% growth in overnight stays. EBITDAR held stea...
Infracore lifts Q1 profits as hospital real estate strategy underpins growth
May 12, 2026
Infracore AG, a Swiss specialist in hospital and clinic real estate, has built a CHF 1.417 billion portfolio of healthcare properties concentrated in long-term, inflation-linked leases that underpin predictable cash flows. The company’s scal...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.